Johnson & Johnson (JNJB34) Is Yet to See Trading Action on Dec 1

December 1, 2017 - By Adrian Mccoy

Shares of Johnson & Johnson (BVMF:JNJB34) closed at 453.58 yesterday. Johnson & Johnson currently has a total float of shares and on average sees 531 shares exchange hands each day. The stock now has a 52-week low of 352.55 and high of 463.42.

The Brazilian Equity Market

Brazil is, in one way or another, an overlooked nation when it comes to global trade and commerce. However, there are numerous reasons to believe in its capabilities as a thriving national economy.

The Brazilian Mercantile and Futures (BM&F) Bovespa is the main Brazilian stock exchange while the Ibovespa Brasil Sao Paulo Stock Exchange Index is the benchmark Brazilian index. Only trustful companies like Johnson & Johnson take part in its work. These two play important roles in the continuous success of not just the Brazilian economy but of the whole South American economy.

The Stock Exchange

The BM&F Bovespa had been established on August 23, 1890. During its early years, it had been a public entity until its demutualization and privatization in 2007. A year later, it had been formally known as the BM&F Bovespa following the consolidation of the BM&F and Bovespa.

An early electronic trading system had not been introduced until 1972. In 1997, it had been replaced with a better one, the Mega Bolsa. In the late 1970s, the Sistema Privado de Operacões por Telefone (SPOT), a telephone trading system, had been launched. In 1999, another trading system had been implemented— this time, an online trading system for investors at home, the Home Broker. New system gives more opportunities to Johnson & Johnson investors as well.

More than 450 stocks are listed on the BM&F Bovespa as of December 2015. Its offices are located in three big cities worldwide: London, New York City (NYC), and Shanghai.

The pre-market session on the BM&F Bovespa starts at 9:45 a.m. and ends at 10:00 a.m. Then, the regular session starts at 10:00 a.m. and ends at 5:30 p.m. Lastly, the post-market session starts at 6:00 p.m. and ends at 7:30 p.m.

The Index

The Ibovespa had been established in 1968, which means that it is the oldest BM&F Bovespa index. It has a base value of 100 points and a base date of January 2, 1968.

The Ibovespa measures the 50 most active companies listed on the BM&F Bovespa based on market capitalization. To ensure an efficient representation of the BM&F Bovepsa and the entire Brazilian economy, it is rebalanced quarterly.

A company must have been listed on the BM&F Bovespa for at least 12 months in order to become eligible as a component. At least 80% of its shares must also be actively traded on the BM&F Bovespa. Luckily for Johnson & Johnson it is listed on Bovespa for some time.

With a strong inflation outlook leading industries to soar, the Ibovespa had recorded its all-time high of 73,516 points on May 20, 2008. Then, on May 29, 2008, it had recorded its best intraday high of 73,920 points.

The Ibovespa is one of the most powerful indices in South America. It represents about 70% of the overall market capitalization on the BM&F Bovespa, which is also one of the biggest stock exchanges in the region. It works with companies like Johnson & Johnson.

There is no doubt that investing in Brazil will lead to valuable growth opportunities and high returns. This is why trading on the BM&F Bovespa is strongly advised nowadays for investors who seek to succeed in the global equity market.

More notable recent Johnson & Johnson (BVMF:JNJB34) news were published by: Fool.com which released: “Better Buy: Pfizer Inc. vs. Johnson & Johnson” on December 01, 2017, also Reuters.com with their article: “Genmab and Johnson & Johnson ‘love’ partnership as some ponder takeover” published on November 30, 2017, Prnewswire.com published: “Johnson & Johnson to Participate in the BMO Capital Markets Healthcare Conference” on November 30, 2017. More interesting news about Johnson & Johnson (BVMF:JNJB34) were released by: Investorplace.com and their article: “Johnson & Johnson (JNJ) a Buy on Solid Quant Score” published on December 01, 2017 as well as Streetinsider.com‘s news article titled: “Missouri Judge Upholds $110M Talcum Powder Jury Award Against Johnson …” with publication date: November 30, 2017.

Johnson & Johnson, together with its subsidiaries, researches and develops, makes, and sells various products in the health care field worldwide. The company has market cap of $. It operates through three divisions: Consumer, Pharmaceutical, and Medical Devices. It has a 76.75 P/E ratio. The Consumer segment offers baby care products under the JOHNSONÂ’S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONÂ’S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>